Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Trading

KayakerBC

Sep 19, 2022 03:22PM

Re: Trading

KOO-KOO2

Sep 20, 2022 02:03PM

Re: Trading

KOO-KOO2

Sep 20, 2022 03:01PM

Re: Trading

KayakerBC

Sep 20, 2022 05:13PM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Trading

in response to

Re: Trading

KayakerBC

posted on Sep 20, 2022 06:22PM

"The Issuer has not filed the following periodic disclosure required by the Legislation:
(a) annual audited financial statements, annual management’s discussion and analysis
and certification of the annual filings for the year ended 30 April 2022."

Annual Filing, year end, 30 April 2022, now all on SEDAR and Zenith's Website

Koo

4 Recommendations